Historically, PLWH have been excluded from participation in oncology trials, which may affect generalizability of findings. represent 70% of these deaths and NECA will increase with aging of the PLWH populace.3 During the past decade, NECA clinical trials of immune checkpoint inhibitors (ICIs) have changed the treatment landscape of many cancers. Historically, PLWH have been … Continue reading Historically, PLWH have been excluded from participation in oncology trials, which may affect generalizability of findings
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed